Cargando…

Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity

BACKGROUND/AIM: The aim of the study was to investigate the outcomes of temporal Zone II-sparing laser photocoagulation combined with intravitreal bevacizumab (IVB) in patients with Type 1 retinopathy of prematurity (ROP) in Zone I. METHODS: Medical records of 74 eyes of 37 infants were analysed. On...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Eoi Jong, Lee, Joo Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180920/ https://www.ncbi.nlm.nih.gov/pubmed/30363696 http://dx.doi.org/10.1155/2018/2376240

Ejemplares similares

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
por: Kim, Rebecca, et al.
Publicado: (2014)

Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity
por: Roohipoor, Ramak, et al.
Publicado: (2018)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
por: Kara, Caner, et al.
Publicado: (2017)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012)

Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022)

Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Ahmed, Ayesha E., et al.
Publicado: (2010)

Structural and refractive outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
por: Hoppe, Charis, et al.
Publicado: (2022)

Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity
por: Fukushima, Yoko, et al.
Publicado: (2018)

Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy
por: Sameen, Murtaza, et al.
Publicado: (2017)

Efficacy of Intravitreal Bevacizumab for the Treatment of Zone I Type 1 Retinopathy of Prematurity
por: Karkhaneh, Reza, et al.
Publicado: (2018)

Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China
por: Linghu, Dandan, et al.
Publicado: (2022)

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy
por: Shin, Yong Woon, et al.
Publicado: (2009)

Comparison of Clinical Outcomes of Intravitreal Bevacizumab and Aflibercept in Type 1 Prethreshold Retinopathy of Prematurity in Posterior Zone II
por: Eftekhari Milani, Amir, et al.
Publicado: (2022)

Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion
por: Ozkaya, Abdullah, et al.
Publicado: (2013)

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity
por: Jeon, Seung Hee, et al.
Publicado: (2021)

Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurity
por: Zhao, Jinfeng, et al.
Publicado: (2020)

The safety and effectiveness of 0.16 mg bevacizumab plus or minus additional laser photocoagulation in the treatment of retinopathy of prematurity
por: Akdogan, Muberra, et al.
Publicado: (2019)

Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016)

Longitudinal Development of Refractive Error in Children Treated With Intravitreal Bevacizumab or Laser for Retinopathy of Prematurity
por: Simmons, Michael, et al.
Publicado: (2021)

Comparison of efficacy of combination therapy of an Intravitreal injection of bevacizumab and photocoagulation versus Pan Retinal Photocoagulation alone in High risk Proliferative Diabetic Retinopathy
por: Rebecca,, et al.
Publicado: (2021)

Transscleral vs transpupillary diode laser photocoagulation for the treatment of zone II type 1 retinopathy of prematurity: Anatomical and refractive outcomes
por: Roohipourmoallai, Ramak, et al.
Publicado: (2022)

COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY
por: Zhang, Guoming, et al.
Publicado: (2017)

Successful Use of Intravitreal Bevacizumab and Pascal Laser Photocoagulation in the Management of Adult Coats’ Disease
por: Raoof, Naz, et al.
Publicado: (2013)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
por: Minami, Tsuyoshi, et al.
Publicado: (2014)

Evaluation of babies with retinopathy of prematurity following intravitreal bevacizumab administration
por: Sahin, Ozlem, et al.
Publicado: (2023)

Refractive profile of children treated with intravitreal bevacizumab for retinopathy of prematurity
por: Pawar, Neelam, et al.
Publicado: (2023)

Role of deferred retinal laser following intravitreal injection of bevacizumab in treatment of severe retinopathy of prematurity
por: Bhat, Vishalakshi, et al.
Publicado: (2023)

Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
por: CP, Juarez, et al.
Publicado: (2013)

Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
por: Das, Gopal K., et al.
Publicado: (2018)

A case of retinopathy of prematurity treated by pattern scan laser photocoagulation
por: Ota, Satoshi, et al.
Publicado: (2014)

Transscleral Diode Laser Photocoagulation for Type 1 Prethreshold Retinopathy of Prematurity
por: Parvaresh, Mohammad Mehdi, et al.
Publicado: (2013)

Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment
por: Gotz-Więckowska, Anna, et al.
Publicado: (2017)

Twelve-year outcomes of bedside laser photocoagulation for severe retinopathy of prematurity
por: Yang, Bingzhi, et al.
Publicado: (2023)

Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review
por: Tsiropoulos, Georgios N., et al.
Publicado: (2022)

Laser Photocoagulation Combined with Intravitreal Triamcinolone Acetonide Injection in Proliferative Diabetic Retinopathy with Macular Edema
por: Choi, Kyung Seek, et al.
Publicado: (2007)

Combined treatment for Coats’ disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases
por: Kodama, Aya, et al.
Publicado: (2014)

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
por: Nicoară, Simona Delia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tgg46pqml13di5tbhhr2mbga19